Gelesis Holdings Quick Ratio 2021-2022 | GLS
Historical quick ratio values for Gelesis Holdings (GLS) over the last 10 years.
| Gelesis Holdings Quick Ratio Historical Data |
| Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
| 2022-09-30 |
$0.04B |
$0.08B |
0.46 |
| 2022-06-30 |
$0.04B |
$0.07B |
0.62 |
| 2022-03-31 |
$0.06B |
$0.05B |
1.10 |
| 2021-12-31 |
$0.05B |
$0.10B |
0.52 |
| 2021-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2021-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2021-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2020-12-31 |
$0.00B |
|
0.00 |
| 2020-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2020-06-30 |
$0.00B |
$0.00B |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.012B |
$0.011B |
|
Gelesis is a consumer-centered biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Gelesis, formerly known as Capstar Special Purpose Acquisition Corp., is based in BOSTON.
|
